LGD-4033 CAS:1165910-22-4

Anti-Cancer growth hormone secretagogue treatment of obesity treatment of frailty in the elderly

LGD-4033 CAS:1165910-22-4 Synonyms: Ostarine(MK-2866);MK-2866 Ostarine;(2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide;((2s)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-MethylpropanaMide) MF:C14H12F6N2O MW:338.2482992 Apperance:White Crystalline Powder Function: A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly Introduction :LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss.

LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.